因賽集團(300781.SZ):2019年年報披露時間變更為4月27日
格隆匯4月15日丨因賽集團(300781.SZ)公佈,公司原計劃於2020年4月21日在中國證監會指定的創業板信息披露網站巨潮資訊網(www.cninfo.com.cn)上披露2019年年度報告及其摘要,受到新冠肺炎疫情影響,全國各地復工都有所延遲,導致公司尚有部分和第三方相關的審計程序仍在進行中。
本着審慎原則及對廣大投資者負責的態度,同時為確保年度報告的準確性及完整性,經公司慎重討論向深圳證券交易所申請並獲得同意,公司《2019年年度報告》披露時間由2020年4月21日變更為2020年4月27日,目前相關審計工作正在緊密進行中,公司將按照規定及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.